The High Cost of Transportation Failure

The United States loses an estimated $150 billion annually to missed medical appointments. While the industry directs billions toward hospital stabilization and telehealth expansion, the underlying logistics of patient arrival remain broken. Healthcare access in rural communities depends on infrastructure that is currently defined by fragmentation and a lack of accountability.

The Medicaid non-emergency medical transportation (NEMT) market exceeds $3 billion in combined federal and state spending. Despite this scale, the system operates through brokers using decades-old systems where missed appointments rarely trigger audits or register as failures. This creates a hidden public health crisis. When a ride does not show up for a patient in rural New Mexico, the failure does not appear in a broker’s complaint log. The dysfunction remains invisible to the vendors managing the benefit.

The economic argument for fixing this specific link in the chain is clear. A Florida State University study cited by the Medical Transportation Access Coalition found that every dollar invested in NEMT returned more than $11 in downstream savings through completed dialysis trips and avoided emergency room visits.

However, the current structural failure persists. Research in the American Journal of Managed Care found Medicaid patients have 66% greater odds of missing a medical appointment than privately insured patients. This disparity exists despite these patients having coverage and transportation benefits. The issue is not just availability, but reliability. In a 2021 report on NEMT beneficiary experiences, advocates noted that brokers sometimes treat complaints about late pickups as “resolved” simply because the member was eventually picked up.

This lack of accountability prevents reform dollars from reaching their intended impact. If patients cannot reliably reach the facilities being funded, the investments in workforce pipelines and hospital stabilization lose their efficacy. The gap is not a data anomaly; it is a failure to integrate logistics into the broader healthcare strategy.

The industry must move beyond treating transportation as a footnote. We should ask: how can we implement accountability metrics for NEMT brokers that track actual patient outcomes rather than just completed trips?